Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Augurex Life Sciences Corp.

News headline image
Augurex Life Sciences Corp. Announces the Launch of the 14-3-3eta Test for Rheumatoid Arthritis Diagnosis and Monitoring with Sonic Reference Laboratory
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex Life Sciences Granted FDA Breakthrough Designation for SPINEstat®, its First-in-Class Diagnostic Test for Axial Spondyloarthritis
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex Announces Expansion of Availability of the JOINTstat® Diagnostic Test for Rheumatoid Arthritis with MitogenDx
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex Secures Health Canada Approval for SPINEstat™, a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex to Present Axial Spondyloarthritis Data and Exhibit at ACR Convergence 2024 in Washington, DC
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex Announces Agreement with ARUP Laboratories to Expand Access to Advanced Rheumatoid Arthritis Diagnosis with the Launch of 14-3-3η (eta) Test
From Augurex Life Sciences Corp.
Via Business Wire
News headline image
Augurex Life Sciences Corp. Names Healthcare Leader Neil Klompas to Succeed Co-Founder Dr. Norma Biln as President and CEO
From Augurex Life Sciences Corp.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.